Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project
Current Language EN
English English Türkçe Türkçe Español Español Português Português Pусский Pусский Filipino Filipino Tiếng Việt Tiếng Việt हिन्दी हिन्दी العربية العربية বাংলা বাংলা Deutsch Deutsch 中文 中文

Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project

Paola Bagella;Nicola Squillace;Elena Ricci;Roberto Gulminetti;Giuseppe Vittorio De Socio;Lucia Taramasso;Giovanni Pellicanò;Barbara Menzaghi;Benedetto Maurizio Celesia;Chiara Dentone;Giancarlo Orofino;Paolo Bonfanti;Giordano Madeddu;
Infection and drug resistance 2019 Vol. 12 pp. 1385--1391
284
bagella2019lipidinfection

Abstract

Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project

Access

DOI:
10.2147/IDR.S203813
URL:
https://www.dovepress.com/getfile.php?file

Citation

ID: 7684
Ref Key: bagella2019lipidinfection
Use this key to autocite in SciMatic or Thesis Manager

References

References

No Bibliography

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
7684
Unique Identifier:
10.2147/IDR.S203813
Network:
Scimatic Chain (ID: 481)
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet
Gas fees required in SCI Coins
Buy SCI

Saymatik Web3.0 Wallet

Google Play
App Store